FOI/2025/26/069
Read more about this page below
| Reference | FOI/2025/26/069 |
|---|---|
| Description | Insourcing contract |
| Date requested | 22/05/2025 |
| Attachments | N/A |
Request
I would be most grateful if you would provide me, under the Freedom of Information Act, details in respect to the contract below: https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.contractsfinder.service.gov.uk%2Fnotice%2F0ae59d86-b5a3-4dda-b2f3-45ed7d110b80%3Forigin%3DSearchResults%26p%3D4&data=05%7C02%7Cclcht.foi.request1%40nhs.net%7Ccb41ef90298d4a5911bd08dd993b0c27%7C37c354b285b047f5b22207b48d774ee3%7C0%7C1%7C638835201083495090%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C40000%7C%7C%7C&sdata=R4aNzqTH77djZwAKkweLfwjafcjZq7cH0DDiVCEygHI%3D&reserved=0
The details we require are:
How did the provider demonstrate best value?
Which providers applied for inclusion?
How are the provider demonstrating best value for money?
What is the cost per patient based on spend and patient numbers?
Has there been a reduction in the waiting list during the contract period?
How many service users have accessed the service?
Please confirm any uncosted or unseen value to patients?
What improved processes has the service delivered to patients and families?
Can you provide summaries of patient/user feedback received during the contract period?
How many complaints or Datix reports have been received related to the service?
What KPIs are used to measure the success of the contract?
Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
Is there an extension clause in the contract and, if so, the duration of the extension?
Has a decision been made yet on whether the contract is being either extended or renewed?
What level of autonomy did the insourcing team have in managing clinics, patient lists, and case prioritisation?
How did the insourcing team integrate with hospital IT systems (e.g., electronic patient records, imaging, lab systems)?
What access did insourcing staff have to hospital resources and facilities?
How was clinical governance maintained under the insourcing arrangement?
How were incidents, complaints, or clinical issues handled and reported?
How did the patient experience compare with in-house service provision?
Response
1. How did the provider demonstrate best value?Please refer to the NHS SBS framework, “Insourcing of Clinical Services”, Framework Agreement Reference: SBS10203.
2. Which providers applied for inclusion?Please refer to the NHS SBS framework, “Insourcing of Clinical Services”, Framework Agreement Reference: SBS10203.
3. How is the provider demonstrating best value for money?Please refer to the NHS SBS framework, “Insourcing of Clinical Services”, Framework Agreement Reference: SBS10203.
4. What is the cost per patient based on spend and patient numbers?Please refer to the NHS SBS framework, “Insourcing of Clinical Services”, Framework Agreement Reference: SBS10203.
5. Could you provide a copy of the service/product specification given to all bidders?Please refer to the NHS SBS framework, “Insourcing of Clinical Services”, Framework Agreement Reference: SBS10203.
6. Is there an extension clause in the contract, and if so, the duration?No, there is no extension clause in this contract.
7. Has there been a reduction in the waiting list during the contract period?Yes.
8. How many service users have accessed the service?Unable to confirm. N/A
9. Please confirm any uncosted or unseen value to patients.no specific data held.
10. What improved processes has the service delivered to patients and families?The service followed existing Trust clinical and operational processes.
11. Can you provide summaries of patient/user feedback received during the contract period?No formal summaries held.
12. How many complaints or Datix reports have been received related to the service?(7) in total.
13. What KPIs are used to measure the success454tr of the contract?The same KPIs used to monitor and evaluate the Trust’s internal services.
14. Has a decision been made yet on whether the contract is being extended or renewed?No decision has been made at this time.
15. What level of autonomy did the insourcing team have in managing clinics, patient lists, and case prioritisation?These aspects were managed by the Trust’s internal teams.
16. How did the insourcing team integrate with hospital IT systems (e.g., EPR, imaging, lab systems)?Insourcing clinical staff were granted access to the Trust’s IT systems required for clinical duties.
17. What access did insourcing staff have to hospital resources and facilities?They were provided with necessary access to deliver clinical services as required.
18. How was clinical governance maintained under the insourcing arrangement?All services operated under the Trust’s established clinical governance processes.
19. How were incidents, complaints, or clinical issues handled and reported?These were managed through the Trust’s internal reporting systems and policies.
20. How did the patient experience compare with in-house service provision?The patient experience was consistent with in-house provision, as the same systems and governance processes were followed.